Scott, DeSantis and Gaetz push for cheaper Rx drugs

A “War on Drugs” is taking place in the U.S., but it’s not what you think.

The “war” in question is being fought between some Republican legislators and Big Pharma, and not by drug cartels and the federal government,

Lawmakers like Florida Gov. Ron DeSantis and Rep. Matt Gaetz (R), who both met with President Trump to discuss rising healthcare costs, are pushing for the importation of less expensive prescription drugs to help ease the rising healthcare costs on Americans.

Who is most likely to win the Democrat nomination?

Completing this poll grants you access to Floridian Press updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

“One of the biggest drivers of this country’s out of control healthcare spending is the cost of prescription drugs,” said Governor DeSantis. “While our prices remain high, our neighbors in Canada are spending significantly less for the same drugs. These price disparities are indefensible and inexcusable and I am ready to act.”

Yesterday, following a Senate Judiciary Committee meeting on the rising costs of prescription drugs, Florida Senator Rick Scott pointed to his Transparent Drug Pricing Act , a bill that he and Senator Hawley introduced to address the cost of prescription drugs in the U.S.

“What was clear from today’s hearing is that there is no good explanation for why American consumers pay more for prescription drugs than consumers in Canada, Europe and Japan,” said Scott. “My bill that I introduced with Senator Hawley puts American consumers first. It would prevent drug companies from charging us more than they charge patients in other countries. I’m sick and tired of my constituents subsidizing European countries so they can keep prices low for their constituents. The system needs to change.”

Scott’s bill has three major components. Here is how they read:

PRICE TRANSPARENCYPharmacies MUST inform patients what it would cost to purchase drugs out-of-pocket instead of using their insurance and co-pay. If patients choose to pay out-of-pocket (which is often cheaper), the total cost would be applied to their deductible. Consumers should not be penalized for shopping for the best price. And they must get this information at the point of sale.

CHOICEInsurance companies MUST inform patients of the total costs of their prescription drugs 60 days prior to open enrollment. This will allow patients to be consumers and shop around for the best deal. Once those costs are set, they cannot be changed for a full 12 months. This will give patients – particularly seniors living on a fixed income – confidence that their drug costs won’t suddenly increase.

FAIRNESSDrug companies CANNOT charge American consumers more for prescription drugs than they charge consumers in other industrialized nations like Great Britain, Canada or Germany. There is no reason why U.S. pharmaceutical companies sell drugs to people in foreign countries far cheaper than what they charge Americans.This provision would sunset after 5 years.

Scott doesn’t appear to be calling for cheaper Canadian drugs, rather calling on U.S. drug companies to sell their drugs at the same discounted price they offer to foreigners.

U.S. pharmaceutical companies are pushing back, and have recently launched a massive nationwide ad campaign questioning the potency and safety concerns of foreign prescription drugs.

Javier Manjarres is a nationally renowned award-winning South Florida-based political journalist owns Diverse New Media, Corp. which publishes Floridianpress.com, Judicialpost.com, shark-tank.com, and Hispolitica.com He enjoys traveling, playing soccer, mixed martial arts, weight-lifting, swimming and biking.
He ran as a Republican in the 2018 congressional primary race in Florida's CD 22.
Javier is also a political consultant, and has also authored "BROWN PEOPLE," which is a book about Hispanic Politics.
Learn more at www.brownpeople.org
Email him at [email protected]